Answers are grounded in this paper and cite their sources.
This investigation highlights supportive care's impact on cell therapies, suggesting improved outcomes in treatment efficacy.
Supportive care is typically differentiated from disease modifying therapies as its function is not to cure patients of a disease. Supportive care forms the backbone of the healthcare infrastructure and is of pivotal importance in facilitating the delivery of advanced therapies such as cell therapies, which can present challenging tolerability profiles. For instance, cytokine release syndrome or immune effector cell-associated neurotoxicity syndrome, has led to the discontinuation of a number of cell therapies during development.
No takes yet. Share an insight, caveat, or question.
Tremble et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: